Qatar Islamic Insurance Group Q.P.S.C. (QSE:QISI)
8.60
0.00 (-0.05%)
At close: Aug 11, 2025, 1:00 PM AST
Regulus Therapeutics Income Statement
Financials in millions QAR. Fiscal year is January - December.
Millions QAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Premiums & Annuity Revenue | 400.71 | 342.39 | 346.01 | 306.63 | 270.32 | 281.99 | Upgrade |
Total Interest & Dividend Income | 36.34 | 38.32 | 31.6 | 31.15 | 18.49 | 16.06 | Upgrade |
Gain (Loss) on Sale of Investments | 0.64 | -0.09 | -20.32 | -1.55 | 0.01 | -1.05 | Upgrade |
Other Revenue | 16.97 | 17.44 | 14.08 | 7.36 | 0.16 | 0.12 | Upgrade |
454.66 | 398.06 | 371.37 | 343.6 | 288.98 | 297.12 | Upgrade | |
Revenue Growth (YoY) | 153.45% | 7.19% | 8.08% | 18.90% | -2.74% | 39.33% | Upgrade |
Policy Benefits | 213.64 | 157.94 | 150.9 | 169.53 | 120.95 | 160.38 | Upgrade |
Policy Acquisition & Underwriting Costs | 16.58 | 13.87 | 14.39 | 3.69 | 14.54 | 15.96 | Upgrade |
Depreciation & Amortization | 0.62 | 0.62 | 0.62 | 0.8 | 0.8 | 2.79 | Upgrade |
Selling, General & Administrative | 54.4 | 67.94 | 60.86 | 47.34 | 41.57 | 36.99 | Upgrade |
Other Operating Expenses | 34.54 | 7.82 | 1.29 | 4.32 | 11.07 | 2.9 | Upgrade |
Total Operating Expenses | 319.77 | 248.18 | 228.06 | 225.68 | 188.92 | 219.02 | Upgrade |
Operating Income | 134.89 | 149.88 | 143.31 | 117.92 | 100.05 | 78.1 | Upgrade |
Interest Expense | -0.02 | -0.03 | -0.05 | -8.02 | -0.13 | - | Upgrade |
Earnings From Equity Investments | - | - | - | -3.25 | -15.08 | -2.37 | Upgrade |
EBT Excluding Unusual Items | 134.87 | 149.85 | 143.26 | 106.65 | 84.85 | 75.73 | Upgrade |
Asset Writedown | -5.6 | -6.15 | -0.46 | -5.31 | -1.77 | - | Upgrade |
Pretax Income | 129.27 | 143.7 | 142.8 | 101.34 | 83.08 | 75.73 | Upgrade |
Net Income | 129.27 | 143.7 | 142.8 | 101.34 | 83.08 | 75.73 | Upgrade |
Net Income to Common | 129.27 | 143.7 | 142.8 | 101.34 | 83.08 | 75.73 | Upgrade |
Net Income Growth | -20.26% | 0.63% | 40.92% | 21.97% | 9.71% | 4.20% | Upgrade |
Shares Outstanding (Basic) | 150 | 150 | 150 | 150 | 150 | 150 | Upgrade |
Shares Outstanding (Diluted) | 150 | 150 | 150 | 150 | 150 | 150 | Upgrade |
EPS (Basic) | 0.86 | 0.96 | 0.95 | 0.68 | 0.55 | 0.50 | Upgrade |
EPS (Diluted) | 0.86 | 0.96 | 0.95 | 0.68 | 0.55 | 0.50 | Upgrade |
EPS Growth | -20.26% | 0.63% | 40.92% | 21.97% | 9.71% | 4.20% | Upgrade |
Free Cash Flow | 142.93 | 132.29 | 84.82 | 147.37 | 141.98 | 87.08 | Upgrade |
Free Cash Flow Per Share | 0.95 | 0.88 | 0.56 | 0.98 | 0.95 | 0.58 | Upgrade |
Dividend Per Share | 0.500 | 0.500 | 0.500 | 0.450 | 0.400 | 0.325 | Upgrade |
Dividend Growth | - | - | 11.11% | 12.50% | 23.08% | -13.33% | Upgrade |
Operating Margin | 29.67% | 37.65% | 38.59% | 34.32% | 34.62% | 26.29% | Upgrade |
Profit Margin | 28.43% | 36.10% | 38.45% | 29.49% | 28.75% | 25.49% | Upgrade |
Free Cash Flow Margin | 31.44% | 33.23% | 22.84% | 42.89% | 49.13% | 29.31% | Upgrade |
EBITDA | 136.4 | 151.39 | 144.89 | 119.11 | 101.3 | 84.41 | Upgrade |
EBITDA Margin | 30.00% | 38.03% | 39.01% | 34.67% | 35.06% | 28.41% | Upgrade |
D&A For EBITDA | 1.51 | 1.52 | 1.58 | 1.19 | 1.25 | 6.31 | Upgrade |
EBIT | 134.89 | 149.88 | 143.31 | 117.92 | 100.05 | 78.1 | Upgrade |
EBIT Margin | 29.67% | 37.65% | 38.59% | 34.32% | 34.62% | 26.29% | Upgrade |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.